Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

207 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Chapter 21: Modelling the impact of HPV vaccines on cervical cancer and screening programmes.
Garnett GP, Kim JJ, French K, Goldie SJ. Garnett GP, et al. Vaccine. 2006 Aug 31;24 Suppl 3:S3/178-86. doi: 10.1016/j.vaccine.2006.05.116. Vaccine. 2006. PMID: 16950005 Review.
Seroepidemiology as basis for design of a human papillomavirus vaccination program.
Ryding J, French KM, Naucler P, Barnabas RV, Garnett GP, Dillner J. Ryding J, et al. Among authors: garnett gp. Vaccine. 2008 Sep 26;26(41):5263-8. doi: 10.1016/j.vaccine.2008.07.041. Epub 2008 Aug 8. Vaccine. 2008. PMID: 18692109
Human papillomavirus and HPV vaccines: a review.
Cutts FT, Franceschi S, Goldie S, Castellsague X, de Sanjose S, Garnett G, Edmunds WJ, Claeys P, Goldenthal KL, Harper DM, Markowitz L. Cutts FT, et al. Bull World Health Organ. 2007 Sep;85(9):719-26. doi: 10.2471/blt.06.038414. Bull World Health Organ. 2007. PMID: 18026629 Free PMC article. Review.
Characteristics of a cluster-randomized phase IV human papillomavirus vaccination effectiveness trial.
Lehtinen M, Apter D, Baussano I, Eriksson T, Natunen K, Paavonen J, Vänskä S, Bi D, David MP, Datta S, Struyf F, Jenkins D, Pukkala E, Garnett G, Dubin G. Lehtinen M, et al. Vaccine. 2015 Mar 3;33(10):1284-90. doi: 10.1016/j.vaccine.2014.12.019. Epub 2015 Jan 12. Vaccine. 2015. PMID: 25593103 Clinical Trial.
Cost-effectiveness analysis of human papillomavirus-vaccination programs to prevent cervical cancer in Austria.
Zechmeister I, Blasio BF, Garnett G, Neilson AR, Siebert U. Zechmeister I, et al. Vaccine. 2009 Aug 13;27(37):5133-41. doi: 10.1016/j.vaccine.2009.06.039. Epub 2009 Jun 28. Vaccine. 2009. PMID: 19567244
Modelling patterns of clearance of HPV-16 infection and vaccination efficacy.
Baussano I, Garnett G, Segnan N, Ronco G, Vineis P. Baussano I, et al. Vaccine. 2011 Feb 1;29(6):1270-7. doi: 10.1016/j.vaccine.2010.11.082. Epub 2010 Dec 8. Vaccine. 2011. PMID: 21145375
The new role of antiretrovirals in combination HIV prevention: a mathematical modelling analysis.
Cremin I, Alsallaq R, Dybul M, Piot P, Garnett G, Hallett TB. Cremin I, et al. AIDS. 2013 Jan 28;27(3):447-58. doi: 10.1097/QAD.0b013e32835ca2dd. AIDS. 2013. PMID: 23296196
The India HPV-vaccine suspension.
Larson HJ, Brocard P, Garnett G. Larson HJ, et al. Lancet. 2010 Aug 21;376(9741):572-3. doi: 10.1016/S0140-6736(10)60881-1. Lancet. 2010. PMID: 20728739 No abstract available.
Uncertainty in estimates of HIV/AIDS: the estimation and application of plausibility bounds.
Grassly NC, Morgan M, Walker N, Garnett G, Stanecki KA, Stover J, Brown T, Ghys PD. Grassly NC, et al. Sex Transm Infect. 2004 Aug;80 Suppl 1(Suppl 1):i31-38. doi: 10.1136/sti.2004.010637. Sex Transm Infect. 2004. PMID: 15249697 Free PMC article.
A systematic review of the epidemiology and interaction of herpes simplex virus types 1 and 2.
Looker KJ, Garnett GP. Looker KJ, et al. Among authors: garnett gp. Sex Transm Infect. 2005 Apr;81(2):103-7. doi: 10.1136/sti.2004.012039. Sex Transm Infect. 2005. PMID: 15800084 Free PMC article. Review.
207 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback